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Abstract
Background: Previous studies are inconclusive on the relationship between parity and cardiovascular disease
(CVD), with few evaluating multiple cardiovascular outcomes. It is also unclear if any relationship between
parity and CVD is independent of breastfeeding. We examined the associations between parity and cardio-
vascular outcomes, including breastfeeding adjustment.
Materials and Methods: Data were from 8,583 White and African American women, 45–64 years of age, in the
Atherosclerosis Risk in Communities Study. Coronary heart disease (CHD), myocardial infarction (MI), heart
failure, and strokes were ascertained from 1987 to 2016 by annual interviews and hospital surveillance. Parity
and breastfeeding were self-reported. Cox proportional hazards regression estimated hazard ratios (HR) for the
association between parity and cardiovascular outcomes, adjusting for baseline sociodemographic, clinical and
lifestyle factors, and breastfeeding.
Results: Women reported no pregnancies (6.0%), or having 0 (1.6%), 1–2 (36.2%), 3–4 (36.4%), or 5+ (19.7%)
live births. During 30 years follow-up, there were 1,352 CHDs, 843 MIs, 750 strokes, and 1,618 heart failure
events. Compared with women with 1–2 prior births, those with prior pregnancies and no live births had greater
incident CHD (HR= 1.64, 95% confidence interval 1.14–2.42) and heart failure risk (1.46, 1.04–2.05), after
adjustment for baseline characteristics. Women with 5+ births had greater risk of CHD (1.29, 1.10–1.52) and
hospitalized MI (1.38, 1.13–1.69), after adjustment for baseline characteristics and breastfeeding.
Conclusions: In a diverse U.S. cohort, a history of 5+ live births is associated with CHD risk, specifically, MI,
independent of breastfeeding. Having a prior pregnancy and no live birth is associated with greater CHD and
heart failure risk.
Keywords: pregnancy, breastfeeding, cardiovascular disease
Introduction
Cardiovascular disease (CVD) is the leading cause ofdeath among women in every major developed coun-
try and most emerging economies.1 In 2016, *296,000
U.S. women died from coronary heart disease (CHD) and
an additional 83,000 women died from stroke.1 One in
three female adults in the United States has some form of
CVD; 6.6 million have CHD and 3.8 million are stroke
survivors.2,3
1Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United
Kingdom.
2Homerton College, Hills Road, University of Cambridge, Cambridge, United Kingdom.
3Department of Obstetrics & Gynecology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
4Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
5Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North
Carolina.
ª Clare Oliver-Williams et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the
Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
JOURNAL OF WOMEN’S HEALTH
Volume 00, Number 00, 2018
Mary Ann Liebert, Inc.
DOI: 10.1089/jwh.2018.7161
1
Pregnancy is a stress test for a woman’s body. Physiolo-
gical changes occurring during pregnancy include weight
gain and accumulation of abdominal fat,4 higher lipid levels,5
increased insulin resistance,6 and structural cardiac changes,
including increased left ventricular mass and end-systolic
volume.7 Although most changes that occur during preg-
nancy are temporary, these changes parallel established CVD
risk factors, and thus may have long-term implications for
cardiovascular health.8 Recognizing that the unique cardio-
vascular demand that occurs during pregnancy can be used to
improve CVD risk prediction, the 2011 American Heart
Association guidelines incorporated obstetric complications
in the assessment of CVD risk in women and made a call for
further research into CVD risk in relation to pregnancy.9
Previous studies have assessed the relationship between
parity and different cardiovascular outcomes, including
CVD,10 CHD,11–13 and stroke.12–14 However, the results of
these studies have been conflicting; previous studies have
found the lowest risk among nulliparous10 or multiparous
women,12 a J-shaped relationship with the nadir of risk for
primiparous women,14 or no relationship.11,13 This may be
due to several reasons, including sociocultural differences in
the populations studied and the evaluation of different out-
comes. Only a few studies have evaluated multiple cardio-
vascular outcomes within the same population, making it
difficult to confirm the relative size and shape of the rela-
tionship across multiple endpoints. These studies have also
all had limitations, which include an inability to differentiate
nulliparous women who chose not to have children from
those who became pregnant, but did not give birth, as a result
of a lack of detailed information12–14 or a small sample
size.10,11 Furthermore, few studies have adjusted for breast-
feeding, in spite of a possible cardioprotective effect,15 which
may be due to decreased risk of type 2 diabetes, hyperlipid-
emia, and hypertension in women who breastfeed.15
To address the limitations of previous studies and inform
preventive efforts to reduce CVD incidence among women,
we sought to examine the association between parity and
several clinically relevant CVD outcomes among a cohort of
women enrolled in the Atherosclerosis Risk in Communities
(ARIC) Study, while also adjusting for breastfeeding. We
hypothesized that women with no prior live births and those
with three or more prior live births would have a higher
incidence of overall CVD and its clinical subtypes compared
with those with one to two prior live births, with a J-shaped
association expected overall.
Materials and Methods
Study population
The ARIC study is a multicenter, population-based, pro-
spective cohort study of middle-aged adults from four U.S.
communities: Forsyth County NC, Jackson MS, suburban
Minneapolis MN, and Washington County MD. Briefly,
15,792 men and women, 45–64 years of age, were recruited
to participate and had their first clinic examination during
1987–1989. Follow-up examinations were conducted in 1990
to 1992 (visit 2), 1993 to 1995 (visit 3), 1996 to 1998 (visit 4),
2011 to 2013 (visit 5), and 2016 to 2017 (visit 6). In addition,
there were annual follow-up interviews to ascertain vital
status and document medical and life course events. Parti-
cipants were predominantly White or African American.
Details about the study design and methods have been de-
scribed previously.16 For this analysis, we excluded men
(n = 7,082), women who did not provide information on live
births (n= 74), and those without any follow-up (n= 1). To
reduce potential residual confounding from racial and so-
cioeconomic differences in exposure and outcome, women
who self-reported their race as other than White or African
American (n = 26), and the small number of African Ameri-
cans in the Minnesota and Washington County cohorts were
also excluded (n = 10 and n = 17, respectively).
This resulted in a final cohort of 8,583 women. Institu-
tional Review Boards at each clinical site approved the study
protocol, and written informed consent was obtained from
all participants.
Measures
Parity. At visit 1, women were asked to report the total
number of live births (parity) in an interviewer-administered
questionnaire. Subsequently at visit 3, women were asked
whether they had ever been pregnant (gravidity), and the total
number of months that they breastfed. We used parity and
gravidity to categorize women into five mutually exclusive
groups: never pregnant, pregnant with no live births, 1–2
births, 3–4 births, and 5+ births.
Covariates. Women reported their age, race, and health
insurance status during an interview-administered question-
naire at visit 1. They also reported cigarette smoking status
(current, former, or never), and reproductive history (use of
birth control pills, use of hormone replacement therapy
[HRT], age at menarche, and menopausal status). Socio-
economic status was calculated from the area deprivation
index using the 2000 Census, which represents a geographic
area-based measure of the socioeconomic deprivation ex-
perienced by a neighborhood based on a range of factors,
including employment, regional income, and vehicle own-
ership. Higher scores indicate greater deprivation.17 Neigh-
borhood deprivation was included instead of individual
markers to ensure adjustment for social and cultural factors
known to be associated with both pregnancy18 and cardio-
vascular outcomes,19 while also indirectly measuring some
individual markers, for example, education.
Years of reproductive life were calculated as the years
from menarche to either menopause, or age at baseline for
premenopausal women. Age at first pregnancy was abstracted
from the visit 3 interview-administered questionnaire. Dec-
ade of menarche was calculated from self-reported age at
menarche, as reported at visit 1, and date of birth. Average
duration of breastfeeding per child, henceforth referred to as
breastfeeding duration, was calculated per child by dividing
the total duration of breastfeeding, reported in months, by the
number of prior live births and was categorized as: no
breastfeeding, <3 months, 3–6 months, and 6+ months.
A combined race-center variable was generated because of
the disparate distribution of race groups across the ARIC
centers. The race-center variable categorized the White and
African American participants separately for each center:
African American Forsyth County, African American Jack-
son, White Forsyth County, White Minneapolis, and White
Washington County.
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At baseline (visit 1), weight and height were measured by
trained technicians at the clinical exam. Weight at age 25 was
also self-reported at baseline. These were used to calculate
BMI at baseline and BMI at age 25 with the following
equation: weight(kg)/height2(m2). Plasma cholesterol and
triglycerides were measured from blood samples collected at
visit 1, as previously described.16
Cardiovascular events. The outcomes of interest were
cardiovascular events, the ascertainment of which has been
detailed previously.20,21 Participants reported cardiovascular
hospitalizations annually, which were verified and aug-
mented by community-wide hospital surveillance of death
certificates and physician review of hospital records. CHD
was defined as a definite or probable myocardial infarction
(MI), fatal CHD, or silent MI, as ascertained from electro-
cardiographic evidence. Definite or probable stroke, both
hemorrhagic and ischemic, hospitalized MI, and heart failure
were also examined. A computer algorithm and physician
reviewer classified events as definite or probable. A com-
posite outcome of both CHD and stroke was derived from
CHD and definite or probable stroke, and thus combined fatal
CHD, MI, ischemic, and hemorrhagic stroke. Follow-up data
for cardiovascular events were available through December
31, 2016.
Missing data
Missing data were imputed using multiple imputation by
chained equations for socioeconomic deprivation, health in-
surance, smoking status, years of reproductive life, oral
contraceptive use, HRT use, decade of menarche, age at first
pregnancy, duration of breastfeeding, and weight at age 25.22
Five imputations were created using a set of appropriate
imputation models constructed of all covariates and outcome
variables.
Statistical analyses
Baseline characteristics of the study population were
compared by parity categories. Continuous variables were
summarized by median and interquartile interval, whereas
categorical variables were summarized by number and per-
centage.
Cox proportional hazards regression models estimated the
risk of cardiovascular events with time since baseline as the
underlying time scale. The proportional hazards assumption
was assessed using the test of Grambsch and Therneau in
nonimputed data.23 Hazard ratios (HR) and 95% confidence
intervals (CI) were calculated for the risk of incident car-
diovascular outcomes by parity categories, with one to two
births as the reference category chosen to assess the hy-
pothesis that nulliparous and multiparous women have a
higher incidence of cardiovascular outcomes.
The association between parity and the risk of five out-
comes, composite CHD and stroke; CHD; hospitalized MI;
heart failure, and stroke, was estimated in four models pro-
gressively adjusting for covariates. These were: model 1
(age), model 2 (age, race-center, socioeconomic deprivation,
health insurance, and smoking status), model 3 (covariates
from model 2 plus duration of reproductive life, oral con-
traceptive pill and HRT use, and decade of menarche), and
model 4 (covariates from model 3 plus age at first pregnancy
and breastfeeding duration). Women with no prior pregnan-
cies were not included in model 4 since they did not have an
age at first pregnancy or breastfeeding duration.
Several sensitivity analyses were conducted. To assess for
any racial differences in the associations, results were strat-
ified by race. Analyses were also conducted, including the
covariates from model 3, plus BMI at age 25 to assess the
robustness of the findings to confounding by BMI closer to
the time of pregnancy. As it is unclear if hyperlipidemia,
diabetes, and hypertension are intermediates on the causal
pathway or confounders, two additional sensitivity analyses
were conducted. Women with diabetes or hypertension at
baseline were excluded (n = 998 and 2,823, respectively), and
thus any women who had diabetes or hypertension before
pregnancy. In separate analyses, we also adjusted for baseline
total cholesterol and triglycerides.
p-Values for all hypothesis tests were two-sided, and sta-
tistical significance was set at p < 0.05. All statistical analyses
were performed using the Stata software package, version
14.2 (Stata Corporation, College Station, TX).
Results
Women reported never being pregnant (6.0%), or having
been pregnant and having had none (1.6%), 1–2 (36.2%), 3–4
(36.4%), or 5+ (19.7%) live births (Table 1). A high per-
centage of women with prior pregnancies and no live births,
and women with 5+ births were more likely to be African
American, to be uninsured, and to have a higher BMI. They
also had higher socioeconomic deprivation as indicated by
higher scores. Women with 5+ births were younger at first
pregnancy (mean: 19 years), and women with no live births
were less likely to have used oral contraceptives.
Women with prior pregnancies and no live births and those
with 5+ births had a greater risk of composite CHD and stroke
compared with women with one to two births, after adjust-
ment for age (HR [model 1] = 1.65, 95% CI 1.20–2.28 and
HR [model 1]= 1.44, 95% CI 1.26–1.63, respectively)
(Table 2). Adjustment for sociodemographic, behavioral, and
reproductive characteristics reduced the magnitude of the
associations, HR (model 3)= 1.49, 95% CI 1.08–2.05 and HR
(model 3) = 1.32; 95% CI 1.16–1.50, respectively. Minimal
attenuation for women with 5+ births was observed after
further adjustment for breastfeeding and age at first preg-
nancy, HR (model 4) = 1.26, 95% CI 1.10–1.44.
When assessing individual cardiovascular events, women
with prior pregnancies and no live births and those with 5+
births had an increased risk of at least one outcome, com-
pared with women with 1–2 births (Table 2). Women with
prior pregnancies and no live births were at greater risk of
both CHD, HR (model 3)= 1.64, 95% CI 1.14–2.39, and heart
failure, HR (model 3) = 1.46, 95% CI 1.04–2.05, after ad-
justment for age, sociodemographic, behavioral, and repro-
ductive factors. Women with 5+ births had a higher risk of
CHD, HR (model 4) = 1.29, 95% CI 1.10–1.52, and hospi-
talized MI, HR (model 4)= 1.38, 95% CI 1.13–1.69, after
adjustment for all factors, including age at first pregnancy and
breastfeeding duration.
Sensitivity analyses adjusting for BMI at age 25 or base-
line total cholesterol and triglycerides, in addition to the so-
ciodemographic, behavioral, and reproductive characteristics
in Model 3, had negligible impact on the results. As did
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exclusion of women with diabetes at baseline (n = 998, 12%
of cohort) or hypertension at baseline (n = 2,823, 33% of
cohort). Stratifying analyses by race showed no discernible
differences in risk (results available upon request).
Discussion
In this analysis of a diverse cohort of women in four U.S.
communities, we estimated the relationship between parity
and several cardiovascular outcomes. Women with prior
pregnancies and no live births were at greater risk of both
CHD and heart failure. Women with 5+ births had a higher
risk of incident CHD and hospitalization for MI, independent
of breastfeeding.
The increased cardiovascular risk associated with multiple
births has been found previously,10,14 although neither study
adjusted for duration of breastfeeding per child. There are
several possible mechanisms that may explain this associa-
tion. There is evidence that repeated pregnancies could result
in cardiometabolic changes, including weight gain,24 in-
creased waist circumference,24 and hyperlipidemia,5 as well
as subclinical atherosclerosis.25 These previous findings are
reflected in our own cohort, where women with multiple
births had a higher BMI, lower high-density lipoprotein
cholesterol, higher triglycerides, and higher low-density li-
poprotein cholesterol at baseline (visit 1) than women with
fewer births (Table 1). The observed association may also
derive from pregnancy-related changes, including increased
left ventricular mass and end-systolic volume,7 although an
association between increasing number of offspring and
greater CVD risk has also been found in men.26 This latter
finding raises the possibility of socioeconomic factors as a
mechanism. Indeed, lower socioeconomic status is associated
with a larger family size27 as well as greater CVD risk factors.
However, as parity is a proxy for multiple factors (in-
cluding socioeconomic deprivation, age at menopause, and
health conditions) and it comprises both pregnancy and child
rearing, it is unclear from our analysis whether these changes
in CVD risk factors reflect the direct impact of physiological
changes from multiple pregnancies, or whether the changes
reflect stressors associated with rearing multiple children.
The negligible impact of adjustment for breastfeeding
Table 2. Hazard Ratios and 95% Confidence Intervals for the Association Between Parity Categories
and Cardiovascular Outcomes: The ARIC Cohort Study, 1987–2016
Never pregnant n = 517
No. of live births in women with prior pregnancies
0 1–2 3–4 5+
n = 138 n = 3,108 n = 3,126 n= 1,694
Composite CHD and stroke
Events/person-years 106/11,897 40/2,628 605/69,316 661/69,887 478/35,386
Model 1 0.95 (0.78–1.17) 1.65 (1.20–2.28) 1 (ref.) 1.08 (0.97–1.20) 1.44 (1.26–1.63)
Model 2 0.95 (0.78–1.18) 1.50 (1.09–2.07) 1 (ref.) 1.11 (0.99–1.24) 1.28 (1.13–1.46)
Model 3 0.95 (0.77–1.18) 1.49 (1.08–2.05) 1 (ref.) 1.13 (1.01–1.26) 1.32 (1.16–1.50)
Model 4 — — 1 (ref.) 1.09 (0.97–1.22) 1.26 (1.10–1.44)
CHD
Events/person-years 77/12,035 30/2,680 435/70,581 472/70,979 338/36,364
Model 1 0.98 (0.77–1.25) 1.72 (1.18–2.49) 1 (ref.) 1.07 (0.94–1.22) 1.41 (1.22–1.63)
Model 2 0.99 (0.78–1.27) 1.66 (1.14–2.42) 1 (ref.) 1.12 (0.98–1.28) 1.34 (1.16–1.57)
Model 3 0.99 (0.77–1.26) 1.64 (1.14–2.39) 1 (ref.) 1.14 (1.00–1.30) 1.39 (1.19–1.61)
Model 4 — — 1 (ref.) 1.09 (0.95–1.25) 1.29 (1.10–1.52)
Hospitalized myocardial infarction
Events/person-years 47/12,308 15/2,828 269/72,103 278/72,555 234/37,137
Model 1 0.96 (0.71–1.31) 1.35 (0.89–2.26) 1 (ref.) 1.35 (0.80–2.26) 1.58 (1.32–1.88)
Model 2 0.98 (0.72–1.34) 1.25 (0.74–2.11) 1 (ref.) 1.07 (0.90–1.27) 1.46 (1.22–1.76)
Model 3 0.97 (0.71–1.32) 1.23 (0.73–2.08) 1 (ref.) 1.09 (0.92–1.29) 1.50 (1.24–1.80)
Model 4 — — 1 (ref.) 1.04 (0.87–1.24) 1.38 (1.13–1.69)
Heart failure
Events/person-years 98/11,596 37/2,490 531/67,714 535/67,293 417/33,443
Model 1 0.99 (0.80–1.23) 1.81 (1.29–2.52) 1 (ref.) 1.00 (0.89–1.13) 1.48 (1.30–1.68)
Model 2 1.03 (0.83–1.27) 1.49 (1.06–2.09) 1 (ref.) 1.04 (0.92–1.17) 1.22 (1.06–1.17)
Model 3 1.01 (0.81–1.25) 1.46 (1.04–2.05) 1 (ref.) 1.06 (0.94–1.20) 1.25 (1.09–1.43)
Model 4 — — 1 (ref.) 1.03 (0.90–1.16) 1.17 (1.01–1.36)
Stroke
Events/person-years 37/12,503 15/2,871 229/72,509 263/73,382 206/37,329
Model 1 0.87 (0.61–1.23) 1.56 (0.92–2.63) 1 (ref.) 1.12 (0.94–1.34) 1.62 (1.34–1.96)
Model 2 0.87 (0.62–2.05) 1.21 (0.72–2.05) 1 (ref.) 1.12 (0.94–1.34) 1.22 (1.00–1.50)
Model 3 0.85 (0.60–1.21) 1.19 (0.70–2.02) 1 (ref.) 1.15 (0.96–1.37) 1.27 (1.04–1.55)
Model 4 — — 1 (ref.) 1.13 (0.94–1.36) 1.25 (1.00–1.55)
Model 1—age.
Model 2—Model 1+combined race and center, socioeconomic deprivation, health insurance, smoking status.
Model 3—Model 2+years of reproductive life, use of the oral contraceptive pill (ever), HRT use, decade of menarche.
Model 4—Model 3+age at first pregnancy and breastfeeding duration per child.
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duration, however, suggests that the differences in risk be-
tween the groups are not due to breastfeeding. An additional
analysis using the variables in model 3 while also adjusting
for BMI at age 25 had no material impact on the results, thus
indicating that BMI close to the time of pregnancy did not
confound the association.
The increased risk of CHD and heart failure found in
women with prior pregnancies, but no previous births may
reflect the increased risk of CHD that has been previously
identified after a history of miscarriage.28 Many of the
women with prior pregnancies but no births will have expe-
rienced miscarriages (as opposed to stillbirths, which occur
less frequently29,30). Thus, the mechanisms proposed to un-
derlie the relationship between miscarriage and CHD, in-
cluding immune disorders, endothelial dysfunction, and
chronic diseases,28 may also underpin the increased risk
identified in the current analysis. Of note, women who only
underwent therapeutic abortions would also be categorized as
having prior pregnancies but no previous births.
Our results are in contrast to some previous studies
that found either an increase CVD risk for all nulliparous
women,12,31 or no increased risk of particular cardiovascular
outcomes, such as heart failure32 and CHD.33 This may be
explained by distinguishing women with prior pregnancies,
but no live births, from those who had never been pregnant. If
women with prior pregnancies are at increased cardiovas-
cular risk, but women who have never been pregnant are not,
then combining these two groups may either give the im-
pression that nulliparous women, as a whole, are at greater
cardiovascular risk, or may diminish any increased risk.
There is a clear need for accurate assessment of CVD risk
in women as it is the leading cause of death; one in three U.S.
women die from CVD each year.2 Parity is a clinically useful
measurement that may be beneficial in CVD risk prediction.
However, to ensure this finding is of public health impor-
tance, the results need to be replicated in other large, diverse
datasets of women with detailed parity information.
The strengths and potential limitations of our study merit
consideration. This analysis included a large sample of
middle-aged women, with a long duration of follow-up
(mean: 23.7 years, maximum: 30.1 years). This study mea-
sured anthropometrics and collected detailed information on
reproductive history, allowing for further assessment of the
potential confounding or mediating role of these relevant
factors and, unlike the majority of previous studies on parity,
did collect information on breastfeeding.
Importantly, the heterogeneous nulliparous group was
separated into those individuals who had been pregnant but
did not have a live birth and those who have never been
pregnant, allowing assessment of the potential impact of this
differentiation on CVD risk.
This study has limitations. There was no information on
pregnancy outcomes and complications, such as preterm
birth, gestational hypertension, or pre-eclampsia, all of which
have been associated with an increased CVD risk.34–36 It is
not clear if BMI, hyperlipidemia, diabetes, or hypertension
status are confounders or intermediates on the causal path-
way. However, adjustment for neither BMI at age 25, nor
baseline total cholesterol and triglycerides, affected the
findings. As the timing of hypertension and diabetes diag-
noses with respect to pregnancy was unknown, women with
diabetes or hypertension at baseline were excluded to assess
the relationship in an otherwise health population. This also
had negligible impact on the results. Finally, there was also a
risk of residual confounding by socioeconomic deprivation.
Marked differences between parity categories were noted for
race and center in combination and insurance status, sug-
gesting a cumulative exposure to adverse social determinants
of health, which may not have been entirely captured by the
socioeconomic measures included in the current analysis.
Furthermore, the analysis was limited to White and Afri-
can American participants, thus the results may not be gen-
eralizable to other ethnicities. It was not possible to
differentiate between therapeutic abortions, miscarriages,
and stillbirths for women who reported prior pregnancies and
no live births, making it unclear whether all nulliparous
women with previous pregnancies are at greater risk of CVD.
Breastfeeding was self-reported and may be misclassified due
to recall bias. Secular trends during the lifetime of study
participants may also have affected results, as hormonal birth
control became widely available in 1960, altering child-
bearing patterns in the United States.
Conclusions
The main finding of our study is that women with prior
pregnancies, but no live births, are at greater risk of incident
CHD and heart failure, whereas women with five or more live
births are at greater risk of CHD and hospitalization from MI,
independent of breastfeeding. Whether this increased risk is
due to the direct impact of pregnancy or through lifestyle
behavior changes is unclear, and requires further research.
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